---
figid: PMC3512067__zee0121268120005
figlink: /pmc/articles/PMC3512067/figure/F5/
number: Fig. 5
caption: Model illustrating how nicotine plus a HFD could exacerbate HFD-induced hepatic
  steatosis in obese mice. Nicotine plus a HFD promotes abdominal lipolysis, resulting
  in FFA release from adipose tissue into the circulation, thereby contributing to
  the buildup of lipids as triglyceride (TG) in the liver. In addition, nicotine plus
  a HFD may also promote de novo lipogenesis through inactivation of AMPK and activation
  of its downstream target ACC, leading to the development of hepatic steatosis. Inactivation
  of AMPK can also stimulate lipogenesis through up-regulation of key genes in the
  lipogenic pathway such as fatty acid synthase (FAS) and ACC by activating the transcription
  factor sterol regulatory element binding protein-1c (SREBP-1c). Intrahepatic lipid
  accumulation can also trigger hepatocellular apoptosis through generation of oxidative
  stress coupled with activation of JNK-mediated apoptotic signaling. AMPK inactivation
  could further sensitize liver cells to nicotine plus HFD-induced apoptosis.
pmcid: PMC3512067
papertitle: Additive Effects of Nicotine and High-Fat Diet on Hepatic Steatosis in
  Male Mice.
reftext: Theodore C. Friedman, et al. Endocrinology. 2012 Dec;153(12):5809-5820.
pmc_ranked_result_index: '48005'
pathway_score: 0.8850555
filename: zee0121268120005.jpg
figtitle: Model illustrating how nicotine plus a HFD could exacerbate HFD-induced
  hepatic steatosis in obese mice
year: '2012'
organisms: Homo sapiens
ndex: d207ac14-dee0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3512067__zee0121268120005.html
  '@type': Dataset
  description: Model illustrating how nicotine plus a HFD could exacerbate HFD-induced
    hepatic steatosis in obese mice. Nicotine plus a HFD promotes abdominal lipolysis,
    resulting in FFA release from adipose tissue into the circulation, thereby contributing
    to the buildup of lipids as triglyceride (TG) in the liver. In addition, nicotine
    plus a HFD may also promote de novo lipogenesis through inactivation of AMPK and
    activation of its downstream target ACC, leading to the development of hepatic
    steatosis. Inactivation of AMPK can also stimulate lipogenesis through up-regulation
    of key genes in the lipogenic pathway such as fatty acid synthase (FAS) and ACC
    by activating the transcription factor sterol regulatory element binding protein-1c
    (SREBP-1c). Intrahepatic lipid accumulation can also trigger hepatocellular apoptosis
    through generation of oxidative stress coupled with activation of JNK-mediated
    apoptotic signaling. AMPK inactivation could further sensitize liver cells to
    nicotine plus HFD-induced apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAG1
  - CASP9
  - ACACB
  - PRKAG2
  - CASP8
  - CASP7
  - ACACA
  - PRKAB2
  - PRKAA2
  - CASP6
  - CASP12
  - TG
  - CASP5
  - CASP4
  - SREBF1
  - PRKAG3
  - CASP3
  - CASP2
  - CASP10
  - MAPK10
  - CASP1
  - PRKAB1
  - MAPK9
  - CASP14
  - MAPK8
  - FAS
  - nicotine
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: â€ TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: SREBP-1c
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: FAS+
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
chemicals:
- word: nicotine
  source: MESH
  identifier: D009538
diseases: []
---
